Opportunity Information: Apply for PAR 15 092
Apply for PAR 15 092
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research.
- This funding opportunity was created on Jan 16, 2015 and posted on Jan 16, 2015.
- Applicants must submit their applications by Nov 17, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Public and State controlled institutions of higher education City or township governments County governments Native American tribal governments (Federally recognized) Small businesses State governments Private institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21) is a National Institutes of Health (NIH) funding opportunity designed to jump-start early stage basic science projects that focus on the biological and genetic contributors to cancer health disparities. The core aim is to support research that digs into why certain populations experience different cancer outcomes by examining mechanisms rooted in biology, genetics, and related fundamental processes. Rather than funding large, mature research programs, this R21 mechanism is meant for pilot and feasibility work that can produce the early evidence, tools, or datasets needed to justify larger follow-on studies, including full-scale mechanistic projects such as R01 grants.
The announcement specifically encourages three broad types of research activity. First, it supports mechanistic studies that investigate biological factors linked to disparities in cancer incidence, progression, or outcomes. This could include foundational work exploring genetic variation, tumor biology differences, immune or inflammatory pathways, metabolism, or other molecular and cellular mechanisms that may help explain unequal cancer burdens across groups. Second, it prioritizes the development and initial testing of new methods and models that make disparity-focused basic research more possible or more rigorous, such as innovative laboratory approaches, experimental systems, or model development that better reflects populations affected by disparities. Third, it allows for secondary data analyses, meaning applicants can leverage existing datasets or previously collected biospecimens to generate new insights without necessarily building a brand-new cohort from scratch.
A major programmatic goal of the FOA is capacity building in the research workforce and infrastructure for basic cancer disparities science. The program is framed not only as a way to fund individual projects, but also as a way to grow a nationwide cohort of investigators with strong basic research expertise in cancer health disparities. In practical terms, the FOA emphasizes expanding and strengthening resources and tools that the field relies on, including biospecimens, cell lines, and validated methods that enable high-quality mechanistic research. By supporting exploratory projects that create or refine such resources, the program aims to make future studies more feasible and to accelerate progress in understanding the biology of cancer disparities.
From an administrative standpoint, this is a discretionary grant opportunity offered under Funding Opportunity Number PAR 15 092, titled "Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21)." It falls under the health and education activity categories and is associated with CFDA number 93.393 (Cancer Cause and Prevention Research). The opportunity does not require cost sharing or matching. It was posted on January 16, 2015, with an original and final closing date of November 17, 2017, and an archive date of December 18, 2017, meaning it is no longer open under this specific announcement version, though similar NIH opportunities may exist under newer FOAs.
Eligibility is broad and includes a wide range of organizations. Eligible applicants include public and private institutions of higher education, nonprofits with and without 501(c)(3) status (excluding institutions of higher education where specified), state and local governments (including counties, cities, townships, special district governments, and independent school districts), public housing authorities, tribal governments (federally recognized) and other tribal organizations, small businesses and for-profit organizations other than small businesses, and various community-based or faith-based organizations. The FOA also explicitly includes many mission-relevant institution types and communities, such as Historically Black Colleges and Universities (HBCUs), Hispanic Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). Foreign (non-U.S.) entities and U.S. territories or possessions are also listed among eligible applicants, along with eligible federal agencies and regional organizations, reflecting the program's interest in building broad, diverse research capacity.
For those seeking the original posting and details, the FOA link provided is http://grants.nih.gov/grants/guide/pa-files/PAR-15-092.html. For access or technical issues related to the announcement, the contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This is the NIH Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21), offered under Funding Opportunity Number PAR 15 092. It is designed to jump-start early stage basic science projects focused on the biological and genetic contributors to cancer health disparities.
What is the main goal of the R21 program described here?
The core goal is to support exploratory, early stage research that helps explain why certain populations experience different cancer outcomes by examining underlying biological, genetic, and other fundamental mechanisms. The intent is to generate early evidence, tools, or datasets that can support larger follow-on studies (including future mechanistic projects such as R01 grants).
What kinds of research does this FOA encourage?
The announcement highlights three broad activity types: (1) mechanistic studies investigating biological factors linked to disparities in cancer incidence, progression, or outcomes; (2) development and initial testing of new methods and models that strengthen disparity-focused basic research; and (3) secondary data analyses using existing datasets or previously collected biospecimens to generate new insights.
What does "mechanistic" cancer disparities research mean in this FOA?
Within this announcement, mechanistic work refers to foundational studies that examine biological explanations for unequal cancer burdens across groups. Examples mentioned include investigating genetic variation, tumor biology differences, immune or inflammatory pathways, metabolism, and other molecular or cellular mechanisms that may contribute to disparities.
Does this opportunity fund large, established research programs?
No. This R21 mechanism is described as being for pilot and feasibility work rather than large, mature research programs. The emphasis is on generating early-stage results or resources that position a project for larger-scale studies later.
Can applicants use existing datasets or biospecimens instead of building a new cohort?
Yes. The FOA explicitly allows secondary data analyses, including leveraging existing datasets or previously collected biospecimens to produce new findings without necessarily creating a new cohort from scratch.
Is method or model development allowed under this FOA?
Yes. One of the three encouraged activity areas is the development and initial testing of new methods and models that make disparity-focused basic research more feasible or rigorous, such as innovative laboratory approaches, experimental systems, or model development that better reflects populations affected by disparities.
How does this program support capacity building?
A major stated goal is to build capacity in the research workforce and infrastructure for basic cancer disparities science. The program is framed as a way to grow a nationwide cohort of investigators with strong basic research expertise in cancer health disparities and to strengthen the resources and tools needed for mechanistic research.
What kinds of research resources does the FOA emphasize strengthening?
The announcement specifically points to expanding and strengthening resources and tools used in the field, including biospecimens, cell lines, and validated methods that enable high-quality mechanistic research. Exploratory projects that create or refine these resources are aligned with the programmatic aims described.
What is the Funding Opportunity Number and title?
The Funding Opportunity Number is PAR 15 092, titled "Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21)."
Which agency is offering this opportunity?
This is a National Institutes of Health (NIH) funding opportunity.
What CFDA number is associated with this grant opportunity?
The opportunity is associated with CFDA number 93.393 (Cancer Cause and Prevention Research).
Are cost sharing or matching funds required?
No. The information provided states that cost sharing or matching is not required.
When was this opportunity posted, and is it still open?
It was posted on January 16, 2015. The original and final closing date listed is November 17, 2017, and the archive date is December 18, 2017. Based on those dates, this specific announcement version is no longer open, though similar NIH opportunities may exist under newer FOAs.
What are the activity categories for this opportunity?
The activity categories listed are health and education.
Who is eligible to apply?
Eligibility is broad and includes many organization types, including public and private institutions of higher education; nonprofits with and without 501(c)(3) status (excluding institutions of higher education where specified); state and local governments (including counties, cities, townships, special district governments, and independent school districts); public housing authorities; federally recognized tribal governments and other tribal organizations; small businesses; for-profit organizations other than small businesses; and community-based or faith-based organizations.
Are minority-serving institutions specifically included in eligibility?
Yes. The FOA explicitly includes institution types and communities such as Historically Black Colleges and Universities (HBCUs), Hispanic Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
Are foreign (non-U.S.) organizations eligible?
Yes. Foreign (non-U.S.) entities are listed among eligible applicants in the information provided.
Are U.S. territories or possessions eligible?
Yes. U.S. territories or possessions are listed among eligible applicants.
Are federal agencies or regional organizations eligible to apply?
Yes. Eligible federal agencies and regional organizations are included in the eligibility list provided.
Where can someone find the original FOA posting?
The FOA link provided is: http://grants.nih.gov/grants/guide/pa-files/PAR-15-092.html
Who should be contacted for access or technical issues related to the announcement?
The contact listed for access or technical issues is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Education Health
Next opportunity: Basic Cancer Research in Cancer Health Disparities (R01)
Previous opportunity: VA GPD TIP Renewal NOFA
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 15 092
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 15 092) also looked into and applied for these:
| Funding Opportunity |
|---|
| Basic Cancer Research in Cancer Health Disparities (R01) Apply for PAR 15 093 Funding Number: PAR 15 093 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| NIDA Translational Avant Garde Award for Development of Medication to Treat Substance Use Disorders (UH2/UH3) Apply for RFA DA 15 017 Funding Number: RFA DA 15 017 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| Assay Validation For High Quality Markers For NCI Supported Clinical Trials (UH2/UH3) Apply for PAR 15 095 Funding Number: PAR 15 095 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Assay Validation For High Quality Markers For NCI Supported Clinical Trials (UH3) Apply for PAR 15 096 Funding Number: PAR 15 096 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Prevention Research in Mid Life Adults (R21) Apply for PA 15 097 Funding Number: PA 15 097 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Prevention Research in Mid Life Adults (R01) Apply for PA 15 098 Funding Number: PA 15 098 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Reductions in Illicit Drug Use and Functional Outcomes (R21/R33) Apply for PA 15 099 Funding Number: PA 15 099 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Maternal Nutrition and Pre pregnancy Obesity Effects on Mothers, Infants and Children (R01) Apply for PA 15 100 Funding Number: PA 15 100 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01) Apply for PAR 15 104 Funding Number: PAR 15 104 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,500,000 |
| Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54) Apply for PAR 15 103 Funding Number: PAR 15 103 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Developing Technologies and Tools to Monitor HIV Brain Reservoirs and How They May be Altered by Exposure to Substances of Abuse (R21/R33) Apply for RFA DA 15 018 Funding Number: RFA DA 15 018 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Gene Environment Interplay in Substance Use Disorders (R01) Apply for PA 15 110 Funding Number: PA 15 110 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Gene Environment Interplay in Substance Use Disorders (R03) Apply for PA 15 111 Funding Number: PA 15 111 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Gene Environment Interplay in Substance Use Disorders (R21) Apply for PA 15 112 Funding Number: PA 15 112 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01) Apply for RFA DA 16 001 Funding Number: RFA DA 16 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Mentored Clinical Scientists Development Program Award in Drug Abuse and Addiction (K12) Apply for PAR 15 119 Funding Number: PAR 15 119 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Identification of Genetic and Genomic Variants by Next Gen in Sequencing Non human Animal Models (U01) Apply for PAR 15 120 Funding Number: PAR 15 120 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| BRAIN Initiative Optimization of Novel Tools and Technologies for Neuroscience Research (R44) Apply for PAR 15 121 Funding Number: PAR 15 121 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Functional Wellness in HIV Maximizing the Treatment Cascade (R01) Apply for PA 15 133 Funding Number: PA 15 133 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Functional Wellness in HIV Maximizing the Treatment Cascade (R21) Apply for PA 15 134 Funding Number: PA 15 134 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 15 092", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.